Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Shareholder feedback
1
Jan 14, 2009 05:34AM

I agree that the CC was well worth it and hope they decide to continue the program. I was impressed with RG's presentation and believe he covered most of the bases. He comes across as a very sharp individual who has good business sense as well as a very good understanding of the technologies they are are focusing on.

Judging by the amount of callers(very few) and the posting response we have seen here on Agora.....it appears that most here are satisfied that they answered most of our questions as best they could, within the confines of a public company.

I must admit that my guesstimates in regard news or other event that prompted the need for a CC were completely wrong.

What I have come to realize/accept is that ptsc is now at an early stage development. Granted they have cash, no debt, and have wholly owned subsidiaries who are generating revenue......but reliance on these efforts to drive share price is going to take awhile, especially considering the number of shares out there. So, I now join those that have proclaimed the only thing that will move the share price north in the next several months is USPTO positive re-examinations and subsequent new licensees. Settlement with the T3 with decent dollars attached is a possibility as well. Can you say limbo?

10
Jan 14, 2009 07:14AM

Jan 14, 2009 07:43AM
5
Jan 14, 2009 08:09AM
1
Jan 14, 2009 08:15AM
2
Jan 14, 2009 08:16AM

Jan 14, 2009 09:45AM
1
Jan 14, 2009 12:21PM
17
Jan 14, 2009 03:45PM
11
Jan 14, 2009 06:27PM
1
Jan 14, 2009 06:53PM
7
Jan 15, 2009 02:36AM

Jan 15, 2009 05:23AM

Jan 15, 2009 07:20AM

Jan 15, 2009 07:36AM

Jan 15, 2009 07:40AM
1
Jan 15, 2009 08:04AM
Share
New Message
Please login to post a reply